pulmicort and Infertility--Male

For many women with inflammatory bowel disease (IBD), the illness coincides with their childbearing years. IBD increases the risk of pregnancy complications and adverse pregnancy outcomes. The multidisciplinary care team should emphasize the importance of medication adherence to achieve preconception disease control and maintain corticosteroid-free remission throughout pregnancy. Medication adjustments to reduce fetal exposure may be considered on an individualized basis in quiescent disease; however, any benefits of such adjustments remain theoretic and there is risk of worsening disease activity. Mode of delivery is determined by obstetric indications, except for women with active perianal disease who should consider cesarean delivery.

Topics: Adalimumab; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Biological Products; Breast Feeding; Budesonide; Certolizumab Pegol; Delivery, Obstetric; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Infliximab; Male; Natalizumab; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Rate